Straatmijer, Tessa; van Schaik, Fiona D.M.; Bodelier, Alexander G.L.; Visschedijk, Marijn; de Vries, Annemarie C.; Ponsioen, Cyriel Y.; Pierik, Marieke; van Bodegraven, Ad A.; West, Rachel L.; de Boer, Nanne K.H.; Srivastava, Nidhi; Romkens, Tessa E.H.; Hoekstra, Jildou; Oldenburg, Bas; Dijkstra, Gerard; van der Woude, Janneke C.; Löwenberg, Mark; Mujagic, Zlatan; Biemans, Vince B.C.; van der Meulen-de Jong, Andrea E.; Duijvestein, Marjolijn
(Wiley-Blackwell, 2023-01)
Background: Tofacitinib is an oral Janus kinase (JAK) inhibitor and is registered for the treatment of ulcerative colitis (UC). The effectiveness of tofacitinib has been evaluated up to 12 months of treatment. Aim: The aim ...